Inhibition of PFKFB3 by PFK158 reduced the levels of several stemness markers, such as CD133 and SOX2; impeded glycolysis; and attenuated tumor growth in SCLC cell line-derived xenografts. This evidence concerns the gene SOX2 and small cell lung carcinoma.